A Wisconsin startup is hoping that its disruptive technology will alter the landscape of osteoarthritis treatment forever.Currently, osteoarthritis, especially in the knee, is often treated with hyaluronic acid-based injectable viscosupplements that are meant to alleviate pain and boost joint movement.But Madison, Wisconsin-based Flex Biomedical has developed a polymer-based synthetic viscosupplement that co-founder and CEO Sal [...]

Madison-based Echometrix expects to offer EchoSoft, software to improve ultrasound diagnosis and management of tendon and ligament injuries, by year’s end, said CEO Sam Adams. Last week, the four-year-old startup filed Securities and Exchange Commission documents seeking to raise $1 million toward that goal.

Mithridion treatments focus on Alzheimer’s disease and schizophrenia. Now it might consider treating progressive supranuclear palsy or a type of early onset Alzheimer’s disease. Mithridion, based in Madison, Wisconsin, said Tuesday it closed on $1.25 million from Venture Investors, The State of Wisconsin Investment Board and Rocket Ventures.

The U.S. Food and Drug Administration in late October granted a 510(k) marketing clearance for NeuWave’s Certus 140TM 2.45 GHz Ablation System. The device attacks tumors with microwave energy in a way that cuts treatment times.

The medical device company from Madison, Wisconsin, said in June it expected to make $1 million this year, and would raise $750,000 to put toward future growth. The company raised $875,000, according to a recent regulatory filing.

The Securities & Exchange Commission charges Brett Cohen and David Meyers in an alleged insider trading scheme involving shares of Exact Sciences Corp. and Sequenom Inc. that netted more than $600,000.The federal Securities & Exchange Commission charged a Baltimore business consultant and his uncle in Cleveland of an insider trading scheme that netted the pair [...]

Madison, Wisconsin, biotechnology company Quincy Bioscience has received an undisclosed “capital infusion” from DaneVest Tech Fund I, an investment group in its hometown. Quincy will used the money to support national sales of its Prevagen Brain Cell Protection dietary supplements, which are supposed to combat memory loss.

Though it’s yet to even get its brain cell protection drug into Phase 1 trials, Quincy Bioscience is far from the typical young biotech on a shoestring budget.For one thing, there’s the Madison, Wisconsin company’s unusual technology. Quincy has patented the use of a jellyfish protein called aequorin to treat disorders that result from excess [...]

Ever heard of the I-Q Corridor? Unless you’re an economic development geek, probably not.The concept, first penned in a little-noticed Wisconsin Technology Council white paper, envisions an economic superhighway of sorts connecting the Twin Cities, Madison, Wis. and Chicago along interstates 90 and 94. The “I” stands for ideas, innovation, investment, intellectual property while the [...]

ConjuGon Inc. has raised $1.9 million in equity to develop drugs that combat bacterial infections, according to a Securities and Exchange Commission filing.The fundraise comes from three investors and is part of an offering that the company hopes will bring in $4.75 million.Late last month, the Food and Drug Administration cleared ConjuGon’s Investigational New Drug [...]